Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22) - Image 1

£99.71

Springer Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Name: Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
Brand: Springer
Price: 99.71 GBP
Availability: InStock

Immunology

This is the most expensive it has ever been. Walk away.

£100 today · previous high £100 · all-time low £100

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 15 days • 15 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 15 days • 1 price levels

Days at Price

Price Analysis

Most common price: £100 (15 days, 100.0%)

Price range: £100 - £100

Price levels: 1 different prices over 15 days

Description

Multiple Myeloma remains an incurable malignancy. As the disease progresses, it invariably becomes resistant to treatment and almost all patients develop refractory disease. There are multiple different types of targeted therapies and many of them are used in combination at different stages of disease. Targeted therapies that are approved to be used include Proteasome Inhibitors, Immunomodulatory Drugs and Monoclonal Antibodies. Second and third generations of these drugs are developed to overcome resistance and they have unique mechanism of actions. Targeted therapies that are undergoing clinical trials include CAR-T cells, bi-specific antibodies, vaccines, ubiquitin ligase inhibitors and BCL-2 inhibitors. This book will help to develop an understanding of targeted therapies in Multiple Myeloma. Its goal is to provide a unique review of the mechanism of action and resistance of the many targeted therapies in Multiple Myeloma by leaders of the field. The book will beuseful for students in medical science, clinicians, health professionals, scientists, pharmaceutical professionals, drug developers, and policy makers. This book will provide an insightful knowledge of the biology of Multiple Myeloma, the mechanism of action and resistance of targeted therapies, application of biomarkers and genomics and possible strategies in overcoming resistance and future development.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3030734390
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Immunology
Domain: Amazon UK
Release Date: 24 July 2021
Listed Since: 07 March 2021

Barcode

No barcode data available

Springer Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Biology and Management of Multiple Myeloma (Current Clinical Oncology)

Springer Hematologic Cancers: Molecular Pathobiology Book

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Clinical Malignant Hematology

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Über die Lebensqualität von Patienten mit akuter myeloischer Leukämie: Eine differenzierende Beobachtungsstudie

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Springer Multiple Myeloma and Plasma Cell Neoplasms Book

Biology and Management of Multiple Myeloma (Current Clinical Oncology)

Hematologic Malignancies in Adults

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Consulting Hematology and Oncology Handbook

Hematologic Malignancies: Methods and Techniques: 55 (Methods in Molecular Medicine, 55)

Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy